Using family history forms in pediatric oncology to identify patients for genetic assessment

Current oncology

M. Bassal¹  E. Smith³  A. Hamilton⁴  S.L. Sawyer⁴  E. Tomiak⁴  J. Hamon⁵ 

[1] Children’s Hospital of Eastern Ontario;Children’s Hospital of Eastern Ontario, University of Ottawa;Children’s Hospital of Eastern Ontario;Children’s Hospital of Eastern Ontario Research Institute;Children’s Hospital of Eastern Ontario, University of Ottawa

关键词: Cancer genetics;    genomics;    inherited cancer predisposition syndromes;    pediatric oncology;    family Histories;    pediatric genetic testing;   

DOI  :  10.3747/co.24.3710

学科分类：肿瘤学

来源: Multimed, Inc.

【 摘 要 】

ObjectiveWe set out to identify and offer genetic testing to the 5%–10% of pediatric cancer patients who have been estimated to carry germline mutations in inherited cancer predisposition syndromes. Clinical genetic testing has become widely available, and thus in busy oncology clinics, tools are needed to identify patients who could benefit from a referral to genetics. MethodsWe studied the clinical utility of administering a family history form in the pediatric oncology long-term follow-up clinic to identify patients who might have an inherited cancer predisposition syndrome. Genetic testing involved primarily Sanger sequencing in clia (Clinical Laboratory Improvement Amendments)–certified laboratories. ResultsOf 57 patients who completed forms, 19 (33.3%) met criteria for referral to genetics. A significant family history of cancer was present for 4 patients, and 12 patients underwent genetic testing. Of 18 genetic tests ordered, none identified a pathogenic mutation, likely because of a small sample size and a candidate-gene approach to testing. Three families were also identified for further assessment based on a family history of breast cancer, with two of families having members eligible forBRCA1andBRCA2testing. ConclusionsGenetic testing in pediatric oncology patients is important to guide the management of patients who have an inherited cancer predisposition syndrome and to identify other family members at risk when mutations are identified. When no mutations are identified, that information is often reassuring to families who are worried about siblings. However, in the absence of an identified genetic cause in a patient, some uncertainty remains.

【 授权许可】

Unknown